CZECRIN Annual Scientific Conference 2022

Regina Demlová

Opening Remarks on the Development of CZECRIN with a Focus on DONets

Irena Doležalová

DONet: EPI

Filip Trbušek

Academic Clinical Trial at the National Institute of Mental Health (NIMH)

Peter Grell

CZECRINonco – RASmiR, GastroPET, GENESIS, EVOLUTION…

Veronika Kunešová

National Stroke Research Network – STROCZECH

Zuzana Moťovská

The Importance of Collaboration and Methodological Infrastructure for High-Quality Academic Clinical Research

Jiří Deml

Pharmacoeconomics as an Integral Part of Clinical Research

Jan Herudek

The Growth Factor FGF2-STAB in the Healing of Chronic Wounds

Michal Kýr

Specific Clinical Trial Designs

Lenka Součková

Clinical Research Unit Certification Programme (CTU/CTC)

Tomáš Juren

The POPART Study – Prophylactic Oropharyngeal Surfactant for Preterm Infants: A Randomised Trial

Eva Hlaváčková

Single-Centre Experience with an Autologous Dendritic Cell Vaccine

Jan Maláska

The Effect of Dexamethasone in Patients with ARDS and COVID-19 – A Prospective, Multicentre, Open-Label, Randomised Controlled Trial with Parallel Groups

Daniela Žáčková

HALF: A Multicentre Academic Phase II Study of Tyrosine Kinase Inhibitor Discontinuation Following a Two-Step Dose Reduction in Patients with Chronic Myeloid Leukaemia – Interim Results

Jacques Demotes

ECRIN | Challenges of new clinical trials designs

Maria Dutarte

EUPATI | Enhancing patient engagement through education

Jon Salmanton Garcia

VACCELERATE | European Corona Vaccine Trial Accelerator Platform

Kateřina Nebeská

CONSCIOUS – educational projects in CT